196 filings
Page 2 of 10
8-K
72c5o
9 Aug 23
Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results
7:06am
8-K
nagp9qkevazasd2v
3 Aug 23
Deciphera Pharmaceuticals Announces Retirement of Daniel L. Flynn, Ph.D., and Appointment of
4:20pm
8-K
1roft mpcl941v
22 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
S-3ASR
1npv1vt9 k1
3 May 23
Automatic shelf registration
8:45am
8-K
1yh7x yiee
3 May 23
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
7:07am
ARS
n8gt9vv
26 Apr 23
Annual report to shareholders
8:14am
DEFA14A
d2zzl5lff
26 Apr 23
Additional proxy soliciting materials
8:06am
S-8
yxekuk3bx
7 Feb 23
Registration of securities for employees
8:42am
8-K
oy48hf38o l4sq0di
7 Feb 23
Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results
7:14am
8-K
n1i44spfy5t4d
20 Jan 23
Entry into a Material Definitive Agreement
4:05pm
424B5
0nmd5lo5
20 Jan 23
Prospectus supplement for primary offering
4:02pm
8-K
11hlcyfg
18 Jan 23
Other Events
5:21pm
424B5
tczyh29i4sr 7ez8l5lh
18 Jan 23
Prospectus supplement for primary offering
5:18pm
8-K
koqsfdj34im5qu
3 Jan 23
Deciphera Pharmaceuticals Announces Planned 2023 Corporate Milestones to Support Continued Evolution to Multi-Product Company
4:13pm
8-K
0jg18q2drgdax7cok1w
3 Nov 22
Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2022 Financial Results
7:07am